1Goldstein S, Ali AS, Sabbah H, et al. Ventricular remodeling. Mechanism and prevention. Cardiol Clin, 1998,16(4):623-632.
2Dzau VJ, Hirsch AT. Emerging role of tissue rennin-angiotensin systems in congestive heart failure. Eur Heart J, 1990,11 (Suppl B) :65-71.
3Smits JF,van Krimpen C, Schoemaker RG, et al. Angiotensin Ⅱ receptor blockade after myocardial infarction in rats:effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol, 1992,20(5) :772-778.
4Taylor K, Patten RD, Smith JJ, et al. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin Ⅱ receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc pharmacol, 1998 ,31 (5) :654-660.
5Jalowy A, Schulz R, Dorge H, et al. Infarct size reduction by ATI-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. JAm Coil Cardiol, 1998 ,32(4): 1787-1796.
6Goodfriend TL, Elliott ME, Catt KJ, et al. Angiotensin receptors and their antagonist. N Engl J Med, 1996,334(25),1649-1654.
